Ozempic Face Pushes Gen X Toward Facelifts Early
Gen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
Evaluate historical worst drawdowns for index funds and translate insights into practical risk controls and withdrawal planning.
14,434 articlesGen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...
Maybank Singapore's CEO, Alvin Lee, is steering a strategy to profit from aging demographics and cross-border wealth ...
In a volatile 2026 market, a defensively positioned dividend stock offers stock ultimate dividend safety. Coca-Cola i...
Thousands gather in Montana for the Little Bighorn 150th anniversary, blending cultural remembrance with a surge in t...
AI infrastructure relies on powerful chip makers. Here's Taiwan Semiconductor (TSM) emerges as a core holding, combin...
Cape Verde's Vozinha has surged to a $17 million valuation as World Cup spotlight boosts a small nation’s brand. Inve...
When North West stepped onto the Paris stage with electric blue hair and punk flair, she sparked more than headlines—...
In a pivotal moment, kevin warsh debuts chair at the Federal Reserve, with policymakers keeping the federal funds rat...
The high-cost DC release posted a weak opening and was trimmed after screenings, fueling questions about DC Studios’ ...
Applied Materials just ripped higher again, sparking a profit-taking debate as the stock taps fresh highs. This repor...
Artificial intelligence is turbocharging drug discovery, cutting years from development timelines and sparking a surg...
A new 530A account aims to boost child wealth, but uptake is tepid as July 4 launches draws near. Experts warn billio...